Reglagene is pleased to announce that we have been selected as one of the three finalists for Tech Parks Arizona Start Up of the Year! We look forward to the virtual Copper Cactus Awards Ceremony on October 17th.
Breakthrough results in quadruplex science! A research group at the University of Cambridge found quadruplex-stranded DNA in healthy human cells for the first time, as displayed in their publication in Nature. University of Cambridge researchers directly observed DNA quadruplex structures as controllers of gene expression in human cells. First author Marco Di Antonio states that “this forces us to rethink the biology of DNA.”
This finding confirms the revolutionary discoveries made by Reglagene’s CSO Laurence Hurley. Reglagene was founded on the thought of targeting quadruplex structures in cancer genes. By doing this, we can target specific genes and regulate their protein production. Today, Reglagene applies Quadruplex Master Switch Technology (QMST) to create and develop Epigenetic Medicines that save patient lives.